Liposomal vaccine delivery systems

By Henriksen-Lacey Malou   Korsholm Karen Smith   Andersen Peter   Perrie Yvonne   Christensen Dennis  

Expert Opinion on Drug Delivery, Vol. 8, Iss. 4, 2011-04 ,pp. : 505-519

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles

By Wang Guilin   Uludag Hasan  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 5, 2008-05 ,pp. : 499-515

Informa Healthcare

Access to resources Recommend Favorite

Drug delivery systems against leishmaniasis? Still an open question

By Romero Eder L   Morilla Maria Jose  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 7, 2008-07 ,pp. : 805-823

Informa Healthcare

Access to resources Recommend Favorite

Drug delivery systems for the topical treatment of cutaneous leishmaniasis

By Carneiro Guilherme   Aguiar Marta Gontijo   Fernandes Ana Paula   Ferreira Lucas Antônio Miranda  

Expert Opinion on Drug Delivery, Vol. 9, Iss. 9, 2012-09 ,pp. : 1083-1097

Informa Healthcare

Access to resources Recommend Favorite

ISCOMs vaccine against experimental leishmaniasis

By Papadopoulou G.   Karagouni E.   Dotsika E.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 885-892

Elsevier

Access to resources Recommend Favorite